GPX-002 is being developed using the same construct for the treatment of both T1D and T2D. In T1D, GPX-002 is designed to work by transforming alpha cells in the pancreas into functional beta-like ...
The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial ... in people with type 2 diabetes (T2D), glucagon levels are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback